Biotech · Private company
Centessa Pharmaceuticals plc
Track this companyFree. Adds Centessa Pharmaceuticals plc to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- A Study of SerpinPC in Participants with Hemophilia B (HemB) with InhibitorsPHASE2 · TERMINATED · started Jul 28, 2023ClinicalTrials.gov NCT05789537 · fetched Nov 12, 2026
- The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia BPHASE2 · TERMINATED · started Jul 6, 2023ClinicalTrials.gov NCT05789524 · fetched Nov 12, 2026
- Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5)TERMINATED · started Dec 9, 2022ClinicalTrials.gov NCT05605678 · fetched Nov 12, 2026
- Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303PHASE3 · TERMINATED · started Feb 10, 2022ClinicalTrials.gov NCT05208866 · fetched Nov 12, 2026
- Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney DiseasePHASE3 · TERMINATED · started Oct 28, 2021ClinicalTrials.gov NCT04064346 · fetched Nov 12, 2026
- Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney DiseasePHASE3 · TERMINATED · started Sep 2, 2020ClinicalTrials.gov NCT04152837 · fetched Nov 12, 2026